These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 31949051)

  • 1. VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.
    ElTanbouly MA; Zhao Y; Nowak E; Li J; Schaafsma E; Le Mercier I; Ceeraz S; Lines JL; Peng C; Carriere C; Huang X; Day M; Koehn B; Lee SW; Silva Morales M; Hogquist KA; Jameson SC; Mueller D; Rothstein J; Blazar BR; Cheng C; Noelle RJ
    Science; 2020 Jan; 367(6475):. PubMed ID: 31949051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VISTA is an immune checkpoint molecule for human T cells.
    Lines JL; Pantazi E; Mak J; Sempere LF; Wang L; O'Connell S; Ceeraz S; Suriawinata AA; Yan S; Ernstoff MS; Noelle R
    Cancer Res; 2014 Apr; 74(7):1924-32. PubMed ID: 24691993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.
    Liu J; Yuan Y; Chen W; Putra J; Suriawinata AA; Schenk AD; Miller HE; Guleria I; Barth RJ; Huang YH; Wang L
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6682-7. PubMed ID: 25964334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity.
    Wang L; Le Mercier I; Putra J; Chen W; Liu J; Schenk AD; Nowak EC; Suriawinata AA; Li J; Noelle RJ
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14846-51. PubMed ID: 25267631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses.
    Wang L; Rubinstein R; Lines JL; Wasiuk A; Ahonen C; Guo Y; Lu LF; Gondek D; Wang Y; Fava RA; Fiser A; Almo S; Noelle RJ
    J Exp Med; 2011 Mar; 208(3):577-92. PubMed ID: 21383057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VISTA Regulates the Development of Protective Antitumor Immunity.
    Le Mercier I; Chen W; Lines JL; Day M; Li J; Sergent P; Noelle RJ; Wang L
    Cancer Res; 2014 Apr; 74(7):1933-44. PubMed ID: 24691994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Affinity Anti-VISTA Antibody Protects against Sepsis by Inhibition of T Lymphocyte Apoptosis and Suppression of the Inflammatory Response.
    Tao T; Bo L; Li T; Shi L; Zhang H; Ye B; Xu Y; Ma Q; Deng X; Zhang G
    Mediators Inflamm; 2021; 2021():6650329. PubMed ID: 34366711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the V-Type Immunoglobulin Domain-Containing Suppressor to T Cell Activation (VISTA) with Agonist Monoclonal Antibodies in Autoimmunity.
    Jung M; Bonavida B
    Crit Rev Immunol; 2022; 42(4):37-49. PubMed ID: 37022358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology.
    Borggrewe M; Kooistra SM; Wesseling EM; Gierschek FL; Brummer ML; Nowak EC; Medeiros-Furquim T; Otto TA; Lee SW; Noelle RJ; Eggen BJL; Laman JD
    Acta Neuropathol Commun; 2021 May; 9(1):91. PubMed ID: 34006329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA.
    Mehta N; Maddineni S; Kelly RL; Lee RB; Hunter SA; Silberstein JL; Parra Sperberg RA; Miller CL; Rabe A; Labanieh L; Cochran JR
    Sci Rep; 2020 Sep; 10(1):15171. PubMed ID: 32938950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the VISTA of microglia: immune checkpoints in CNS inflammation.
    Borggrewe M; Kooistra SM; Noelle RJ; Eggen BJL; Laman JD
    J Mol Med (Berl); 2020 Oct; 98(10):1415-1430. PubMed ID: 32856125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VISTA nonredundantly regulates proliferation and CD69low γδ T cell accumulation in the intestine in murine sepsis.
    Gray CC; Armstead BE; Chung CS; Chen Y; Ayala A
    J Leukoc Biol; 2024 May; 115(6):1005-1019. PubMed ID: 38035776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness.
    Broughton TWK; ElTanbouly MA; Schaafsma E; Deng J; Sarde A; Croteau W; Li J; Nowak EC; Mabaera R; Smits NC; Kuta A; Noelle RJ; Lines JL
    Front Immunol; 2019; 10():2641. PubMed ID: 31803182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-checkpoint protein VISTA in allergic, autoimmune disease and transplant rejection.
    Zheng M; Zhang Z; Yu L; Wang Z; Dong Y; Tong A; Yang H
    Front Immunol; 2023; 14():1194421. PubMed ID: 37435070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.
    Ceeraz S; Eszterhas SK; Sergent PA; Armstrong DA; Ashare A; Broughton T; Wang L; Pechenick D; Burns CM; Noelle RJ; Vincenti MP; Fava RA
    Arthritis Res Ther; 2017 Dec; 19(1):270. PubMed ID: 29216931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VSIG-3 as a ligand of VISTA inhibits human T-cell function.
    Wang J; Wu G; Manick B; Hernandez V; Renelt M; Erickson C; Guan J; Singh R; Rollins S; Solorz A; Bi M; Li J; Grabowski D; Dirkx J; Tracy C; Stuart T; Ellinghuysen C; Desmond D; Foster C; Kalabokis V
    Immunology; 2019 Jan; 156(1):74-85. PubMed ID: 30220083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways.
    ElTanbouly MA; Schaafsma E; Smits NC; Shah P; Cheng C; Burns C; Blazar BR; Noelle RJ; Mabaera R
    Front Immunol; 2020; 11():580187. PubMed ID: 33178206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
    Deng J; Li J; Sarde A; Lines JL; Lee YC; Qian DC; Pechenick DA; Manivanh R; Le Mercier I; Lowrey CH; Varn FS; Cheng C; Leib DA; Noelle RJ; Mabaera R
    Cancer Immunol Res; 2019 Jul; 7(7):1079-1090. PubMed ID: 31088847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VISTA Targeting of T-cell Quiescence and Myeloid Suppression Overcomes Adaptive Resistance.
    Schaafsma E; Croteau W; ElTanbouly M; Nowak EC; Smits NC; Deng J; Sarde A; Webber CA; Rabadi D; Cheng C; Noelle R; Lines JL
    Cancer Immunol Res; 2023 Jan; 11(1):38-55. PubMed ID: 36260656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRIG1 engages ligand VISTA and impairs tumor-specific CD8
    Ta HM; Roy D; Zhang K; Alban T; Juric I; Dong J; Parthasarathy PB; Patnaik S; Delaney E; Gilmour C; Zakeri A; Shukla N; Rupani A; Phoon YP; Liu C; Avril S; Gastman B; Chan T; Wang LL
    Sci Immunol; 2024 May; 9(95):eadi7418. PubMed ID: 38758807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.